An association between OCBs and the HLA DRB1*15 allele suggests that immunological changes affecting the prognosis of the disease might be regulated by genetic factors, i.e., supports an idea of genetic origin of MS. The gene discussed is HLA-DRB1; the disease is myeloid sarcoma.